25 XP   0   0   10

Emergent Biosolutions Inc
Buy, Hold or Sell?

Let's analyse Emergent Biosolutions Inc together

PenkeI guess you are interested in Emergent Biosolutions Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Emergent Biosolutions Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Emergent Biosolutions Inc

I send you an email if I find something interesting about Emergent Biosolutions Inc.

Quick analysis of Emergent Biosolutions Inc (30 sec.)










What can you expect buying and holding a share of Emergent Biosolutions Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.22
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$12.44
Expected worth in 1 year
$-1.62
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
$-13.84
Return On Investment
-744.0%

For what price can you sell your share?

Current Price per Share
$1.86
Expected price per share
$1.42 - $2.718
How sure are you?
50%

1. Valuation of Emergent Biosolutions Inc (5 min.)




Live pricePrice per Share (EOD)

$1.86

Intrinsic Value Per Share

$-175.53 - $12.15

Total Value Per Share

$-163.10 - $24.59

2. Growth of Emergent Biosolutions Inc (5 min.)




Is Emergent Biosolutions Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$649.3m$1.4b-$603.8m-68.9%

How much money is Emergent Biosolutions Inc making?

Current yearPrevious yearGrowGrow %
Making money-$189.9m-$55.9m-$133.9m-70.5%
Net Profit Margin-76.1%-20.6%--

How much money comes from the company's main activities?

3. Financial Health of Emergent Biosolutions Inc (5 min.)




What can you expect buying and holding a share of Emergent Biosolutions Inc? (5 min.)

Welcome investor! Emergent Biosolutions Inc's management wants to use your money to grow the business. In return you get a share of Emergent Biosolutions Inc.

What can you expect buying and holding a share of Emergent Biosolutions Inc?

First you should know what it really means to hold a share of Emergent Biosolutions Inc. And how you can make/lose money.

Speculation

The Price per Share of Emergent Biosolutions Inc is $1.86. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Emergent Biosolutions Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Emergent Biosolutions Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $12.44. Based on the TTM, the Book Value Change Per Share is $-3.51 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.94 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Emergent Biosolutions Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.95-51.0%-3.63-195.0%-1.07-57.6%-0.39-21.1%-0.05-2.9%
Usd Book Value Change Per Share-0.92-49.3%-3.51-188.9%-0.94-50.7%-0.35-18.6%0.084.1%
Usd Dividend Per Share0.000.0%0.052.9%0.000.0%0.010.6%0.031.7%
Usd Total Gains Per Share-0.92-49.3%-3.46-186.0%-0.94-50.7%-0.34-18.0%0.115.8%
Usd Price Per Share2.40-5.88-26.23-45.64-40.75-
Price to Earnings Ratio-0.63--0.48--39.35--2.07-0.67-
Price-to-Total Gains Ratio-2.62--1.98--133.21-61.10-58.35-
Price to Book Ratio0.19-0.32-0.91-1.92-2.32-
Price-to-Total Gains Ratio-2.62--1.98--133.21-61.10-58.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.86
Number of shares537
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.01
Usd Book Value Change Per Share-3.51-0.35
Usd Total Gains Per Share-3.46-0.34
Gains per Quarter (537 shares)-1,857.78-180.17
Gains per Year (537 shares)-7,431.10-720.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1116-7547-744123-744-731
2232-15095-1487246-1488-1452
3349-22642-2230370-2232-2173
4465-30189-2973493-2976-2894
5581-37737-37165116-3720-3615
6697-45284-44596139-4464-4336
7814-52831-52027163-5208-5057
8930-60379-59458186-5951-5778
91046-67926-66889209-6695-6499
101162-75473-74320232-7439-7220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%8.012.00.040.0%23.017.00.057.5%53.022.00.070.7%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%9.011.00.045.0%25.015.00.062.5%52.020.03.069.3%
Dividend per Share2.00.02.050.0%2.00.010.016.7%2.00.018.010.0%4.00.036.010.0%8.00.067.010.7%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%9.011.00.045.0%25.015.00.062.5%52.020.03.069.3%

Fundamentals of Emergent Biosolutions Inc

About Emergent Biosolutions Inc

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Fundamental data was last updated by Penke on 2024-04-13 12:41:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Emergent Biosolutions Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Emergent Biosolutions Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -17.9% means that $-0.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Emergent Biosolutions Inc:

  • The MRQ is -17.9%. The company is making a huge loss. -2
  • The TTM is -76.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-76.1%+58.2%
TTM-76.1%YOY-20.6%-55.4%
TTM-76.1%5Y-14.0%-62.0%
5Y-14.0%10Y-3.7%-10.4%
1.1.2. Return on Assets

Shows how efficient Emergent Biosolutions Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.7% Return on Assets means that Emergent Biosolutions Inc generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Emergent Biosolutions Inc:

  • The MRQ is -2.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.7%TTM-8.7%+6.0%
TTM-8.7%YOY-1.9%-6.8%
TTM-8.7%5Y-1.1%-7.7%
5Y-1.1%10Y0.2%-1.2%
1.1.3. Return on Equity

Shows how efficient Emergent Biosolutions Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.6% Return on Equity means Emergent Biosolutions Inc generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Emergent Biosolutions Inc:

  • The MRQ is -7.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.6%TTM-22.1%+14.5%
TTM-22.1%YOY-3.9%-18.2%
TTM-22.1%5Y-3.1%-19.0%
5Y-3.1%10Y-0.5%-2.6%

1.2. Operating Efficiency of Emergent Biosolutions Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Emergent Biosolutions Inc is operating .

  • Measures how much profit Emergent Biosolutions Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -15.1% means the company generated $-0.15  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Emergent Biosolutions Inc:

  • The MRQ is -15.1%. The company is operating very inefficient. -2
  • The TTM is -28.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-28.0%+12.8%
TTM-28.0%YOY-16.2%-11.8%
TTM-28.0%5Y0.1%-28.1%
5Y0.1%10Y4.4%-4.3%
1.2.2. Operating Ratio

Measures how efficient Emergent Biosolutions Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.15 means that the operating costs are $1.15 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Emergent Biosolutions Inc:

  • The MRQ is 1.151. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.274. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.151TTM1.274-0.123
TTM1.274YOY1.227+0.047
TTM1.2745Y1.027+0.247
5Y1.02710Y0.959+0.068

1.3. Liquidity of Emergent Biosolutions Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Emergent Biosolutions Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.04 means the company has $1.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Emergent Biosolutions Inc:

  • The MRQ is 1.043. The company is just able to pay all its short-term debts.
  • The TTM is 0.926. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.043TTM0.926+0.118
TTM0.926YOY3.371-2.446
TTM0.9265Y2.605-1.679
5Y2.60510Y3.938-1.334
1.3.2. Quick Ratio

Measures if Emergent Biosolutions Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.46 means the company can pay off $0.46 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Emergent Biosolutions Inc:

  • The MRQ is 0.465. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.492. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.465TTM0.492-0.028
TTM0.492YOY1.679-1.187
TTM0.4925Y1.516-1.023
5Y1.51610Y2.775-1.259

1.4. Solvency of Emergent Biosolutions Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Emergent Biosolutions Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Emergent Biosolutions Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.65 means that Emergent Biosolutions Inc assets are financed with 64.6% credit (debt) and the remaining percentage (100% - 64.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Emergent Biosolutions Inc:

  • The MRQ is 0.646. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.608. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.646TTM0.608+0.038
TTM0.608YOY0.486+0.122
TTM0.6085Y0.526+0.082
5Y0.52610Y0.439+0.087
1.4.2. Debt to Equity Ratio

Measures if Emergent Biosolutions Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 182.6% means that company has $1.83 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Emergent Biosolutions Inc:

  • The MRQ is 1.826. The company is just able to pay all its debts with equity.
  • The TTM is 1.568. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.826TTM1.568+0.258
TTM1.568YOY0.967+0.601
TTM1.5685Y1.141+0.427
5Y1.14110Y0.860+0.282

2. Market Valuation of Emergent Biosolutions Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Emergent Biosolutions Inc generates.

  • Above 15 is considered overpriced but always compare Emergent Biosolutions Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.63 means the investor is paying $-0.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Emergent Biosolutions Inc:

  • The EOD is -0.490. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.633. Based on the earnings, the company is expensive. -2
  • The TTM is -0.477. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.490MRQ-0.633+0.142
MRQ-0.633TTM-0.477-0.156
TTM-0.477YOY-39.345+38.869
TTM-0.4775Y-2.070+1.594
5Y-2.07010Y0.673-2.744
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Emergent Biosolutions Inc:

  • The EOD is 1.173. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.513. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.254. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.173MRQ1.513-0.340
MRQ1.513TTM0.254+1.260
TTM0.254YOY-4.166+4.420
TTM0.2545Y-1.751+2.005
5Y-1.75110Y-0.545-1.206
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Emergent Biosolutions Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Emergent Biosolutions Inc:

  • The EOD is 0.150. Based on the equity, the company is cheap. +2
  • The MRQ is 0.193. Based on the equity, the company is cheap. +2
  • The TTM is 0.325. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.150MRQ0.193-0.043
MRQ0.193TTM0.325-0.132
TTM0.325YOY0.908-0.584
TTM0.3255Y1.916-1.592
5Y1.91610Y2.322-0.405
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Emergent Biosolutions Inc.

3.1. Institutions holding Emergent Biosolutions Inc

Institutions are holding 79.504% of the shares of Emergent Biosolutions Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc18.00490.0006939919796351711.4219
2023-12-31Vanguard Group Inc5.69820.0002297463832827212.4046
2023-12-31Charles Schwab Investment Management Inc5.50540.00182873984131293484.1058
2023-12-31Millennium Management LLC4.01440.00222095662-1570717-42.8411
2023-12-31Hotchkis & Wiley Capital Management LLC3.15540.01411647243-781247-32.1701
2023-12-31Goldman Sachs Group Inc2.88060.00031503774845188128.3337
2023-09-30Jacobs Levy Equity Management, Inc.2.38690.02511246020115730.9375
2023-12-31Morgan Stanley - Brokerage Accounts2.36640.00031235356625316102.5041
2023-09-30Citadel Advisors Llc2.29970.0009120054357914093.1988
2023-12-31Geode Capital Management, LLC2.10180.00031097219781847.6724
2023-12-31Two Sigma Advisers, LLC2.08360.00611087700204001.9114
2023-12-31State Street Corporation2.03620.00011062951-69004-6.096
2023-12-31Two Sigma Investments LLC1.98950.0057103860026240.2533
2023-09-30D. E. Shaw & Co LP1.7940.0033936518-41399-4.2334
2023-12-31Prescott Group Capital Management LLC1.63470.3588853349554162185.2226
2023-12-31Assenagon Asset Management SA1.59830.0053834372651480356.2102
2023-12-31Dimensional Fund Advisors, Inc.1.26090.0005658220-143383-17.887
2023-12-31Qube Research & Technologies1.18990.00296211776211770
2023-12-31Bridgeway Capital Management, LLC1.18090.0317616457-252148-29.0291
2023-12-31Renaissance Technologies Corp1.04840.0025473005473000
Total 64.23010.462233530280+4283369+12.8%

3.2. Funds holding Emergent Biosolutions Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-29Schwab Fundamental US Small Company ETF5.72680.09072989606165980.5583
2024-02-29Vanguard Total Stock Mkt Idx Inv2.95680.0003154354500
2024-03-28iShares Russell 2000 ETF2.61020.005313626216570.0482
2024-02-29BlackRock Advantage Small Cap Core Instl1.94940.09371017634-61520-5.7008
2024-03-28Invesco FTSE RAFI US 1500 Small-Mid ETF1.66510.092386922200
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.43880.0024751111312504.3411
2024-01-31Fidelity Small Cap Index0.98730.003551541368071.3384
2024-03-28iShares Russell 2000 Value ETF0.96680.0102504718-320-0.0634
2024-02-29Schwab Fundamental US Small Company Idx0.9190.0816479732-10051-2.0521
2023-12-31Bridgeway Small-Cap Value0.75420.1629393733-200000-33.6852
2023-12-31Bridgeway Small Cap Value0.75420.1645393733-200000-33.6852
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.62990.002532881166002.0483
2023-12-31Palisade Small Cap Core Equity0.54970.0483286969-30188-9.5183
2024-01-31Goldman Sachs Small Cp Val Insghts Instl0.50510.050726369000
2024-03-31Blackrock Russell 2000 Alpha Tilts Fd A0.47590.0658248457-14484-5.5085
2024-03-29Schwab US Small-Cap ETF™0.46320.003624180300
2024-02-29Fidelity Extended Market Index0.43520.0019227172-60259-20.9647
2024-02-29BlackRock Advantage Small Cap Gr Instl0.43270.1264225864117325.4789
2023-12-31Vanguard Strategic Small-Cap Equity Inv0.42720.0359222996136275157.1419
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.36610.00519111300
Total 25.01361.047513057943-366903-2.8%

3.3. Insider Transactions

Insiders are holding 2.885% of the shares of Emergent Biosolutions Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-02Kathryn C ZoonSELL18308.35
2023-05-25Kathryn C ZoonSELL17008.38

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Emergent Biosolutions Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.918-3.514+283%-0.942+3%-0.346-62%0.077-1296%
Book Value Per Share--12.43816.787-26%28.354-56%23.335-47%18.125-31%
Current Ratio--1.0430.926+13%3.371-69%2.605-60%3.938-74%
Debt To Asset Ratio--0.6460.608+6%0.486+33%0.526+23%0.439+47%
Debt To Equity Ratio--1.8261.568+16%0.967+89%1.141+60%0.860+112%
Dividend Per Share---0.054-100%-0%0.011-100%0.031-100%
Eps---0.948-3.626+282%-1.072+13%-0.392-59%-0.054-94%
Free Cash Flow Per Share--0.397-1.235+411%-0.718+281%0.163+143%0.169+135%
Free Cash Flow To Equity Per Share--0.487-3.801+881%1.587-69%0.009+5276%0.547-11%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0020%
Intrinsic Value_10Y_max--12.155--------
Intrinsic Value_10Y_min---175.535--------
Intrinsic Value_1Y_max--0.754--------
Intrinsic Value_1Y_min---4.672--------
Intrinsic Value_3Y_max--2.619--------
Intrinsic Value_3Y_min---25.309--------
Intrinsic Value_5Y_max--4.910--------
Intrinsic Value_5Y_min---58.141--------
Market Cap97098324.000-29%125288160.000306825483.500-59%1369034165.000-91%2432525067.000-95%2152368681.960-94%
Net Profit Margin---0.179-0.761+325%-0.206+15%-0.140-22%-0.037-80%
Operating Margin---0.151-0.280+85%-0.162+7%0.001-18707%0.044-444%
Operating Ratio--1.1511.274-10%1.227-6%1.027+12%0.959+20%
Pb Ratio0.150-29%0.1930.325-41%0.908-79%1.916-90%2.322-92%
Pe Ratio-0.490+23%-0.633-0.477-25%-39.345+6118%-2.070+227%0.673-194%
Price Per Share1.860-29%2.4005.878-59%26.225-91%45.639-95%40.751-94%
Price To Free Cash Flow Ratio1.173-29%1.5130.254+497%-4.166+375%-1.751+216%-0.545+136%
Price To Total Gains Ratio-2.027+23%-2.616-1.981-24%-133.212+4993%61.096-104%58.351-104%
Quick Ratio--0.4650.492-6%1.679-72%1.516-69%2.775-83%
Return On Assets---0.027-0.087+224%-0.019-30%-0.011-61%0.002-1591%
Return On Equity---0.076-0.221+190%-0.039-49%-0.031-59%-0.005-94%
Total Gains Per Share---0.918-3.460+277%-0.942+3%-0.336-63%0.108-949%
Usd Book Value--649300000.000876350000.000-26%1480200000.000-56%1235330000.000-47%954784725.000-32%
Usd Book Value Change Per Share---0.918-3.514+283%-0.942+3%-0.346-62%0.077-1296%
Usd Book Value Per Share--12.43816.787-26%28.354-56%23.335-47%18.125-31%
Usd Dividend Per Share---0.054-100%-0%0.011-100%0.031-100%
Usd Eps---0.948-3.626+282%-1.072+13%-0.392-59%-0.054-94%
Usd Free Cash Flow--20700000.000-64475000.000+411%-37475000.000+281%9220000.000+125%9148325.000+126%
Usd Free Cash Flow Per Share--0.397-1.235+411%-0.718+281%0.163+143%0.169+135%
Usd Free Cash Flow To Equity Per Share--0.487-3.801+881%1.587-69%0.009+5276%0.547-11%
Usd Market Cap97098324.000-29%125288160.000306825483.500-59%1369034165.000-91%2432525067.000-95%2152368681.960-94%
Usd Price Per Share1.860-29%2.4005.878-59%26.225-91%45.639-95%40.751-94%
Usd Profit---49500000.000-189925000.000+284%-55950000.000+13%-19645000.000-60%-2531125.000-95%
Usd Revenue--276600000.000262525000.000+5%280225000.000-1%331255000.000-16%236208325.000+17%
Usd Total Gains Per Share---0.918-3.460+277%-0.942+3%-0.336-63%0.108-949%
 EOD+4 -4MRQTTM+22 -13YOY+16 -175Y+7 -2810Y+7 -29

4.2. Fundamental Score

Let's check the fundamental score of Emergent Biosolutions Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.490
Price to Book Ratio (EOD)Between0-10.150
Net Profit Margin (MRQ)Greater than0-0.179
Operating Margin (MRQ)Greater than0-0.151
Quick Ratio (MRQ)Greater than10.465
Current Ratio (MRQ)Greater than11.043
Debt to Asset Ratio (MRQ)Less than10.646
Debt to Equity Ratio (MRQ)Less than11.826
Return on Equity (MRQ)Greater than0.15-0.076
Return on Assets (MRQ)Greater than0.05-0.027
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Emergent Biosolutions Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.749
Ma 20Greater thanMa 502.253
Ma 50Greater thanMa 1002.376
Ma 100Greater thanMa 2002.257
OpenGreater thanClose1.900
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Retained Earnings  734,000-183,000551,000-261,300289,700-262,00027,700-49,500-21,800



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,834,900
Total Liabilities1,185,600
Total Stockholder Equity649,300
 As reported
Total Liabilities 1,185,600
Total Stockholder Equity+ 649,300
Total Assets = 1,834,900

Assets

Total Assets1,834,900
Total Current Assets679,500
Long-term Assets1,155,400
Total Current Assets
Cash And Cash Equivalents 111,700
Net Receivables 191,000
Inventory 328,900
Other Current Assets 47,900
Total Current Assets  (as reported)679,500
Total Current Assets  (calculated)679,500
+/-0
Long-term Assets
Property Plant Equipment 399,000
Intangible Assets 566,600
Long-term Assets Other 178,100
Long-term Assets  (as reported)1,155,400
Long-term Assets  (calculated)1,143,700
+/- 11,700

Liabilities & Shareholders' Equity

Total Current Liabilities651,300
Long-term Liabilities534,300
Total Stockholder Equity649,300
Total Current Liabilities
Short-term Debt 417,200
Short Long Term Debt 413,700
Accounts payable 112,200
Other Current Liabilities 94,700
Total Current Liabilities  (as reported)651,300
Total Current Liabilities  (calculated)1,037,800
+/- 386,500
Long-term Liabilities
Long term Debt 446,500
Long-term Liabilities Other 28,900
Long-term Liabilities  (as reported)534,300
Long-term Liabilities  (calculated)475,400
+/- 58,900
Total Stockholder Equity
Common Stock100
Retained Earnings -21,800
Accumulated Other Comprehensive Income -5,700
Other Stockholders Equity 676,700
Total Stockholder Equity (as reported)649,300
Total Stockholder Equity (calculated)649,300
+/-0
Other
Capital Stock100
Cash and Short Term Investments 111,700
Common Stock Shares Outstanding 51,900
Current Deferred Revenue27,200
Liabilities and Stockholders Equity 1,834,900
Net Debt 765,800
Net Invested Capital 1,509,500
Net Working Capital 28,200
Property Plant and Equipment Gross 794,200
Short Long Term Debt Total 877,500



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-31
> Total Assets 
0
0
0
69,056
0
0
0
100,332
0
0
130,831
238,255
203,893
206,996
226,751
273,508
273,641
277,919
287,396
290,788
303,782
326,385
316,802
344,689
342,791
345,747
366,237
500,319
471,277
493,984
512,962
546,864
514,687
527,140
540,025
564,230
538,385
555,614
595,464
626,630
823,251
837,249
869,291
945,262
917,845
943,323
976,548
1,043,592
1,035,897
1,056,466
932,026
970,111
951,639
970,483
1,024,202
1,070,206
1,068,467
1,138,891
1,173,623
2,229,400
2,153,700
2,321,300
2,333,800
2,329,300
2,278,700
2,466,100
2,616,300
2,883,200
2,900,100
2,915,200
2,867,500
2,959,000
2,780,400
2,735,400
2,908,500
3,166,600
2,949,800
2,178,800
1,893,100
1,834,900
1,834,9001,893,1002,178,8002,949,8003,166,6002,908,5002,735,4002,780,4002,959,0002,867,5002,915,2002,900,1002,883,2002,616,3002,466,1002,278,7002,329,3002,333,8002,321,3002,153,7002,229,4001,173,6231,138,8911,068,4671,070,2061,024,202970,483951,639970,111932,0261,056,4661,035,8971,043,592976,548943,323917,845945,262869,291837,249823,251626,630595,464555,614538,385564,230540,025527,140514,687546,864512,962493,984471,277500,319366,237345,747342,791344,689316,802326,385303,782290,788287,396277,919273,641273,508226,751206,996203,893238,255130,83100100,33200069,056000
   > Total Current Assets 
0
0
0
41,695
0
0
0
59,116
0
0
57,192
147,337
103,690
99,610
107,363
144,310
139,629
140,028
151,974
152,679
163,921
203,722
195,417
193,814
191,536
194,446
210,836
243,493
216,203
223,844
236,765
254,418
239,542
243,215
252,935
263,347
237,079
248,159
234,015
273,115
327,203
345,449
383,632
432,175
405,811
435,488
473,490
538,612
528,160
528,047
479,995
510,218
489,166
509,741
556,034
485,389
476,649
541,308
563,148
620,800
528,500
692,700
700,000
686,200
626,600
795,900
958,800
1,195,900
1,181,100
1,162,100
1,111,500
1,272,100
1,100,300
1,084,200
1,118,500
1,210,700
1,221,300
777,700
354,100
679,500
679,500354,100777,7001,221,3001,210,7001,118,5001,084,2001,100,3001,272,1001,111,5001,162,1001,181,1001,195,900958,800795,900626,600686,200700,000692,700528,500620,800563,148541,308476,649485,389556,034509,741489,166510,218479,995528,047528,160538,612473,490435,488405,811432,175383,632345,449327,203273,115234,015248,159237,079263,347252,935243,215239,542254,418236,765223,844216,203243,493210,836194,446191,536193,814195,417203,722163,921152,679151,974140,028139,629144,310107,36399,610103,690147,33757,1920059,11600041,695000
       Cash And Cash Equivalents 
0
0
0
6,821
0
0
0
36,294
0
0
19,906
76,418
67,645
33,980
24,266
105,730
92,747
84,007
104,688
91,473
61,380
102,508
118,777
102,924
116,384
102,193
151,229
169,019
136,925
122,094
125,346
143,901
150,425
161,843
197,901
141,666
130,238
156,243
172,561
179,338
160,215
168,130
242,249
280,499
216,515
214,841
308,718
312,795
341,016
333,395
298,932
271,513
270,170
315,627
340,991
178,292
163,606
190,237
339,358
112,200
137,200
177,400
139,200
167,800
181,500
268,800
415,000
621,300
547,800
447,500
403,800
576,100
435,800
358,100
240,900
642,600
430,200
88,600
87,800
111,700
111,70087,80088,600430,200642,600240,900358,100435,800576,100403,800447,500547,800621,300415,000268,800181,500167,800139,200177,400137,200112,200339,358190,237163,606178,292340,991315,627270,170271,513298,932333,395341,016312,795308,718214,841216,515280,499242,249168,130160,215179,338172,561156,243130,238141,666197,901161,843150,425143,901125,346122,094136,925169,019151,229102,193116,384102,924118,777102,50861,38091,473104,68884,00792,747105,73024,26633,98067,64576,41819,9060036,2940006,821000
       Short-term Investments 
0
0
0
1,250
0
0
0
0
0
0
190
0
0
0
0
0
0
0
0
0
0
0
0
215
215
215
215
2,029
6,338
5,048
3,499
1,966
1,966
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,043
1,043
1,043
1,043
1,043
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,800
8,900
0
5,900
0
8,500
0
08,50005,90008,9004,800000000000000001,0431,0431,0431,0431,0430000000000000000000001,9661,9663,4995,0486,3382,0292152152152150000000000001900000001,250000
       Net Receivables 
0
0
0
18,637
0
0
0
3,293
0
0
6,815
44,200
7,190
34,184
54,999
18,817
25,018
32,451
24,070
34,855
84,136
65,399
37,223
67,446
48,438
64,553
31,143
48,054
35,942
64,399
73,482
83,659
63,450
57,237
26,703
96,043
73,726
60,871
30,681
66,238
80,738
94,944
52,373
60,191
81,082
112,860
60,470
127,340
73,331
75,933
81,464
148,474
134,853
108,630
129,357
146,085
129,134
189,489
76,955
271,100
121,500
218,100
281,200
275,300
172,700
258,600
196,100
230,900
184,400
261,900
254,600
274,700
181,800
175,000
191,300
158,400
155,900
290,100
216,500
191,000
191,000216,500290,100155,900158,400191,300175,000181,800274,700254,600261,900184,400230,900196,100258,600172,700275,300281,200218,100121,500271,10076,955189,489129,134146,085129,357108,630134,853148,47481,46475,93373,331127,34060,470112,86081,08260,19152,37394,94480,73866,23830,68160,87173,72696,04326,70357,23763,45083,65973,48264,39935,94248,05431,14364,55348,43867,44637,22365,39984,13634,85524,07032,45125,01818,81754,99934,1847,19044,2006,815003,29300018,637000
       Other Current Assets 
0
0
0
2,984
0
0
0
3,088
0
0
2,213
1,998
1,970
2,561
2,475
2,866
3,074
4,691
5,700
6,623
4,253
17,470
17,470
9,923
9,633
10,584
11,144
11,669
14,835
15,041
16,459
10,231
8,348
8,127
10,086
10,477
10,967
12,463
14,448
12,896
14,982
16,345
26,477
25,811
26,080
23,079
24,232
21,541
25,613
22,045
18,439
16,229
13,411
14,955
16,797
18,200
28,713
22,209
21,090
31,700
58,800
65,200
49,400
20,600
24,300
32,300
77,600
36,700
42,400
66,300
88,500
70,500
82,000
125,600
140,000
57,900
267,300
44,700
62,400
47,900
47,90062,40044,700267,30057,900140,000125,60082,00070,50088,50066,30042,40036,70077,60032,30024,30020,60049,40065,20058,80031,70021,09022,20928,71318,20016,79714,95513,41116,22918,43922,04525,61321,54124,23223,07926,08025,81126,47716,34514,98212,89614,44812,46310,96710,47710,0868,1278,34810,23116,45915,04114,83511,66911,14410,5849,6339,92317,47017,4704,2536,6235,7004,6913,0742,8662,4752,5611,9701,9982,213003,0880002,984000
   > Long-term Assets 
0
0
0
27,361
0
0
0
41,216
0
0
73,639
90,918
100,203
107,386
119,388
129,198
134,012
137,891
135,422
138,109
139,861
122,663
121,385
150,875
151,255
151,301
155,401
256,826
255,074
270,140
276,197
292,446
275,145
283,925
287,090
300,883
301,306
307,455
361,449
353,515
496,048
491,800
485,659
513,087
512,034
507,835
503,058
504,980
507,737
528,419
452,031
459,893
462,473
460,742
468,168
584,817
591,818
597,583
610,475
1,608,600
1,625,200
1,628,600
1,633,800
1,643,100
1,652,100
1,670,200
1,657,500
1,687,300
1,719,000
1,753,100
1,756,000
1,686,900
1,680,100
1,651,200
1,790,000
1,955,900
1,728,500
1,401,100
1,172,300
1,155,400
1,155,4001,172,3001,401,1001,728,5001,955,9001,790,0001,651,2001,680,1001,686,9001,756,0001,753,1001,719,0001,687,3001,657,5001,670,2001,652,1001,643,1001,633,8001,628,6001,625,2001,608,600610,475597,583591,818584,817468,168460,742462,473459,893452,031528,419507,737504,980503,058507,835512,034513,087485,659491,800496,048353,515361,449307,455301,306300,883287,090283,925275,145292,446276,197270,140255,074256,826155,401151,301151,255150,875121,385122,663139,861138,109135,422137,891134,012129,198119,388107,386100,20390,91873,6390041,21600027,361000
       Property Plant Equipment 
0
0
0
27,269
0
0
0
30,645
0
0
59,632
78,174
87,836
96,576
103,479
110,218
115,421
118,365
120,898
124,656
127,245
110,383
112,645
131,834
133,493
136,839
141,257
152,701
157,963
172,481
188,245
208,973
218,749
224,894
232,310
241,764
242,344
248,504
263,056
264,240
303,468
302,455
304,211
313,979
315,489
320,084
327,643
331,856
342,083
359,034
362,544
376,448
381,102
380,240
386,457
407,210
411,269
419,157
435,075
510,200
513,400
520,500
529,100
542,300
549,200
580,100
606,500
644,100
692,900
743,500
768,700
800,100
807,500
798,400
806,700
817,600
716,800
395,500
395,400
399,000
399,000395,400395,500716,800817,600806,700798,400807,500800,100768,700743,500692,900644,100606,500580,100549,200542,300529,100520,500513,400510,200435,075419,157411,269407,210386,457380,240381,102376,448362,544359,034342,083331,856327,643320,084315,489313,979304,211302,455303,468264,240263,056248,504242,344241,764232,310224,894218,749208,973188,245172,481157,963152,701141,257136,839133,493131,834112,645110,383127,245124,656120,898118,365115,421110,218103,47996,57687,83678,17459,6320030,64500027,269000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,029
5,029
5,029
5,502
5,502
5,502
5,502
5,502
5,502
5,502
5,502
14,294
13,954
47,188
47,188
41,301
41,984
41,984
52,585
52,585
54,902
54,902
54,902
41,001
41,001
41,001
41,001
41,001
49,130
49,130
49,130
49,130
259,700
267,700
268,300
268,600
268,600
266,400
266,300
266,500
266,700
266,500
266,600
266,500
224,900
224,900
224,900
224,900
218,200
218,200
218,200
218,200
0
0218,200218,200218,200218,200224,900224,900224,900224,900266,500266,600266,500266,700266,500266,300266,400268,600268,600268,300267,700259,70049,13049,13049,13049,13041,00141,00141,00141,00141,00154,90254,90254,90252,58552,58541,98441,98441,30147,18847,18813,95414,2945,5025,5025,5025,5025,5025,5025,5025,5025,0295,0295,029000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,596
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000004000000000000000000000015,5960000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,400
51,400
51,400
51,400
51,400
41,800
41,800
41,800
41,800
41,800
41,800
72,571
71,948
119,228
116,978
114,764
136,144
134,002
114,438
102,239
99,876
97,511
94,445
35,419
33,865
32,311
30,756
29,202
119,597
115,685
111,773
107,861
811,600
798,100
783,400
768,700
741,900
737,100
722,200
678,100
663,100
648,200
633,100
618,600
604,600
590,600
576,600
722,700
728,800
608,900
592,800
582,800
566,600
566,600582,800592,800608,900728,800722,700576,600590,600604,600618,600633,100648,200663,100678,100722,200737,100741,900768,700783,400798,100811,600107,861111,773115,685119,59729,20230,75632,31133,86535,41994,44597,51199,876102,239114,438134,002136,144114,764116,978119,22871,94872,57141,80041,80041,80041,80041,80041,80051,40051,40051,40051,40051,400000000000000000000000000000
       Other Assets 
0
0
0
92
0
0
0
10,571
0
0
14,007
12,744
12,367
10,810
15,909
18,980
18,591
19,526
14,524
13,453
12,616
12,280
8,740
19,041
17,762
14,462
14,144
104,125
97,111
97,659
87,952
83,473
56,396
59,031
54,780
59,119
58,962
58,951
98,393
89,275
192,580
189,345
181,448
199,108
196,545
187,751
175,415
173,124
165,654
169,385
89,487
83,445
81,371
80,502
81,711
177,607
15,734
17,523
18,409
27,100
46,000
40,700
48,000
65,600
73,800
77,100
83,000
115,000
81,700
80,300
102,200
57,300
27,900
51,300
14,800
191,300
169,100
178,900
366,700
0
0366,700178,900169,100191,30014,80051,30027,90057,300102,20080,30081,700115,00083,00077,10073,80065,60048,00040,70046,00027,10018,40917,52315,734177,60781,71180,50281,37183,44589,487169,385165,654173,124175,415187,751196,545199,108181,448189,345192,58089,27598,39358,95158,96259,11954,78059,03156,39683,47387,95297,65997,111104,12514,14414,46217,76219,0418,74012,28012,61613,45314,52419,52618,59118,98015,90910,81012,36712,74414,0070010,57100092000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,970
18,278
0
0
0
0
0
11,087
11,087
11,087
0
1,203
16,411
17,043
0
12,863
13,481
13,747
11,286
11,124
18,192
11,286
0
5,022
5,022
4,864
0
12,656
12,654
12,652
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000012,65212,65412,65604,8645,0225,022011,28618,19211,12411,28613,74713,48112,863017,04316,4111,203011,08711,08711,0870000018,27827,97000000000000000000000000000000
> Total Liabilities 
0
0
0
46,107
0
0
0
40,595
0
0
74,072
99,783
65,872
66,976
83,258
102,349
95,044
96,804
94,567
91,439
91,001
95,983
79,420
100,874
93,675
83,704
87,243
126,758
112,354
112,754
128,459
130,137
102,592
104,618
111,613
122,102
102,580
106,532
128,607
137,465
345,756
349,482
356,153
392,061
379,967
381,072
371,236
383,575
368,915
383,794
384,403
373,906
341,220
349,884
360,492
157,861
187,187
200,545
206,974
1,218,500
1,166,000
1,332,400
1,298,800
1,240,800
1,203,900
1,267,300
1,364,800
1,436,200
1,377,300
1,371,500
1,344,800
1,340,000
1,205,100
1,222,200
1,459,200
1,783,600
1,747,200
1,222,500
1,195,900
1,185,600
1,185,6001,195,9001,222,5001,747,2001,783,6001,459,2001,222,2001,205,1001,340,0001,344,8001,371,5001,377,3001,436,2001,364,8001,267,3001,203,9001,240,8001,298,8001,332,4001,166,0001,218,500206,974200,545187,187157,861360,492349,884341,220373,906384,403383,794368,915383,575371,236381,072379,967392,061356,153349,482345,756137,465128,607106,532102,580122,102111,613104,618102,592130,137128,459112,754112,354126,75887,24383,70493,675100,87479,42095,98391,00191,43994,56796,80495,044102,34983,25866,97665,87299,78374,0720040,59500046,107000
   > Total Current Liabilities 
0
0
0
34,186
0
0
0
30,093
0
0
38,466
64,347
30,465
32,261
35,511
55,661
49,381
52,370
51,568
54,021
54,206
72,910
57,307
54,701
48,123
45,444
49,858
75,719
70,934
72,504
68,931
71,054
42,995
44,465
50,572
61,907
43,541
48,778
56,632
56,651
72,324
76,427
81,417
92,936
80,297
86,962
88,725
99,611
90,455
103,858
110,306
105,856
67,706
72,926
75,432
100,068
86,870
96,813
102,014
200,400
248,400
301,200
275,300
216,300
207,100
293,700
299,300
384,500
370,200
377,800
365,400
373,800
249,200
276,700
268,400
1,229,900
1,215,700
693,200
664,000
651,300
651,300664,000693,2001,215,7001,229,900268,400276,700249,200373,800365,400377,800370,200384,500299,300293,700207,100216,300275,300301,200248,400200,400102,01496,81386,870100,06875,43272,92667,706105,856110,306103,85890,45599,61188,72586,96280,29792,93681,41776,42772,32456,65156,63248,77843,54161,90750,57244,46542,99571,05468,93172,50470,93475,71949,85845,44448,12354,70157,30772,91054,20654,02151,56852,37049,38155,66135,51132,26130,46564,34738,4660030,09300034,186000
       Short-term Debt 
0
0
0
1,046
0
0
0
1,408
0
0
3,918
11,403
2,638
2,597
3,485
15,346
18,524
18,707
18,739
21,248
21,316
34,308
19,087
20,791
20,797
12,186
12,038
17,187
16,927
10,229
4,920
5,360
3,280
4,057
4,148
4,470
4,470
4,470
4,470
25,955
27,308
30,313
33,765
40,174
27,588
34,755
36,253
43,150
32,675
34,772
20,000
20,000
27,664
26,200
38,419
42,713
31,353
42,582
49,396
10,100
10,100
10,100
10,100
12,900
26,300
29,100
30,900
33,800
26,000
28,800
31,600
31,600
31,600
31,600
21,200
957,300
950,700
455,200
413,600
417,200
417,200413,600455,200950,700957,30021,20031,60031,60031,60031,60028,80026,00033,80030,90029,10026,30012,90010,10010,10010,10010,10049,39642,58231,35342,71338,41926,20027,66420,00020,00034,77232,67543,15036,25334,75527,58840,17433,76530,31327,30825,9554,4704,4704,4704,4704,1484,0573,2805,3604,92010,22916,92717,18712,03812,18620,79720,79119,08734,30821,31621,24818,73918,70718,52415,3463,4852,5972,63811,4033,918001,4080001,046000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
251,000
0
0
0
246,892
20,000
20,000
20,000
268,094
248,394
248,693
248,994
13,457
13,469
13,482
0
10,100
10,100
10,100
10,100
12,900
26,300
29,100
30,900
33,800
26,000
28,800
31,600
31,600
31,600
31,600
21,200
957,300
950,700
455,200
413,600
413,700
413,700413,600455,200950,700957,30021,20031,60031,60031,60031,60028,80026,00033,80030,90029,10026,30012,90010,10010,10010,10010,100013,48213,46913,457248,994248,693248,394268,09420,00020,00020,000246,892000251,0000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
5,520
0
0
0
10,425
0
0
16,571
27,366
19,003
17,347
19,383
17,979
17,863
19,933
16,673
18,254
17,186
17,568
21,236
17,159
16,164
20,300
22,518
25,409
24,034
32,182
33,902
40,530
28,316
23,301
27,348
31,297
23,871
25,711
29,018
27,521
36,643
36,968
39,351
40,930
40,583
41,824
41,248
45,966
45,611
58,974
46,342
34,649
27,179
29,604
30,111
41,751
46,216
41,629
38,874
80,700
78,600
124,500
91,300
94,800
84,200
84,800
102,800
136,100
142,200
151,800
135,200
128,900
107,300
106,200
103,800
103,500
124,200
108,300
112,700
112,200
112,200112,700108,300124,200103,500103,800106,200107,300128,900135,200151,800142,200136,100102,80084,80084,20094,80091,300124,50078,60080,70038,87441,62946,21641,75130,11129,60427,17934,64946,34258,97445,61145,96641,24841,82440,58340,93039,35136,96836,64327,52129,01825,71123,87131,29727,34823,30128,31640,53033,90232,18224,03425,40922,51820,30016,16417,15921,23617,56817,18618,25416,67319,93317,86317,97919,38317,34719,00327,36616,5710010,4250005,520000
       Other Current Liabilities 
0
0
0
9,364
0
0
0
10,920
0
0
8,999
24,146
7,734
11,341
11,914
21,434
12,094
12,829
15,336
14,287
15,477
20,556
16,729
16,496
10,921
12,717
15,049
25,284
24,057
24,757
25,750
23,802
11,116
15,603
17,502
24,329
13,192
16,548
21,106
1,341
3,193
3,813
2,488
6,487
6,860
3,040
2,490
2,553
2,580
2,983
39,140
44,171
2,216
1,710
2,393
2,372
2,337
2,852
2,954
99,000
95,000
89,600
66,300
6,700
7,600
147,100
53,800
83,100
122,000
100,200
82,300
213,300
110,300
138,900
118,600
169,100
128,000
28,900
114,800
94,700
94,700114,80028,900128,000169,100118,600138,900110,300213,30082,300100,200122,00083,10053,800147,1007,6006,70066,30089,60095,00099,0002,9542,8522,3372,3722,3931,7102,21644,17139,1402,9832,5802,5532,4903,0406,8606,4872,4883,8133,1931,34121,10616,54813,19224,32917,50215,60311,11623,80225,75024,75724,05725,28415,04912,71710,92116,49616,72920,55615,47714,28715,33612,82912,09421,43411,91411,3417,73424,1468,9990010,9200009,364000
   > Long-term Liabilities 
0
0
0
11,921
0
0
0
10,502
0
0
35,606
35,436
35,407
34,715
47,747
46,688
45,663
44,434
42,999
37,418
36,795
23,073
22,113
46,173
45,552
38,260
37,385
51,039
41,420
40,250
59,528
59,083
59,597
60,153
61,041
60,195
59,039
57,754
71,975
80,814
273,432
273,055
274,736
299,125
299,670
294,110
282,511
283,964
278,460
279,936
274,097
268,050
273,514
276,958
285,060
57,793
100,317
103,732
104,960
1,018,100
917,600
1,031,200
1,023,500
1,024,500
996,800
973,600
1,065,500
1,051,700
1,007,100
993,700
979,400
966,200
955,900
945,500
1,190,800
553,700
531,500
529,300
531,900
534,300
534,300531,900529,300531,500553,7001,190,800945,500955,900966,200979,400993,7001,007,1001,051,7001,065,500973,600996,8001,024,5001,023,5001,031,200917,6001,018,100104,960103,732100,31757,793285,060276,958273,514268,050274,097279,936278,460283,964282,511294,110299,670299,125274,736273,055273,43280,81471,97557,75459,03960,19561,04160,15359,59759,08359,52840,25041,42051,03937,38538,26045,55246,17322,11323,07336,79537,41842,99944,43445,66346,68847,74734,71535,40735,43635,6060010,50200011,921000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,074
48,873
0
0
0
0
0
57,187
56,069
54,952
62,000
251,000
251,000
251,000
0
251,000
253,000
253,000
253,000
247,192
247,393
247,793
248,094
248,394
248,693
248,994
13,457
13,469
13,482
13,495
784,500
732,400
830,400
813,300
798,400
762,900
758,100
848,500
841,000
833,100
825,200
817,300
809,400
801,500
793,600
1,032,100
448,500
447,700
448,000
0
0
00448,000447,700448,5001,032,100793,600801,500809,400817,300825,200833,100841,000848,500758,100762,900798,400813,300830,400732,400784,50013,49513,48213,46913,457248,994248,693248,394248,094247,793247,393247,192253,000253,000253,000251,0000251,000251,000251,00062,00054,95256,06957,1870000048,87329,07400000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,970
18,278
0
0
0
0
0
11,087
11,087
11,087
0
1,203
16,411
17,043
0
12,863
13,481
13,747
11,286
11,124
18,192
11,286
0
5,022
5,022
4,864
0
12,656
12,654
12,652
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000012,65212,65412,65604,8645,0225,022011,28618,19211,12411,28613,74713,48112,863017,04316,4111,203011,08711,08711,0870000018,27827,97000000000000000000000000000000
       Other Liabilities 
0
0
0
100
0
0
0
0
0
0
3,051
4,068
4,661
4,695
4,259
4,100
3,961
3,829
3,348
1,483
1,587
1,823
1,613
1,246
1,387
1,350
1,160
20,800
11,763
11,176
10,655
4,989
2,005
2,013
2,175
1,891
1,852
1,685
17,023
17,395
22,432
22,055
23,736
48,125
48,670
41,110
29,511
30,964
31,268
32,543
26,304
19,956
25,120
28,265
36,066
44,336
86,848
90,250
91,465
233,600
173,800
184,600
188,600
199,900
200,000
182,000
185,600
210,700
140,800
136,900
162,100
156,800
131,800
151,900
142,900
90,400
0
81,300
69,100
0
069,10081,300090,400142,900151,900131,800156,800162,100136,900140,800210,700185,600182,000200,000199,900188,600184,600173,800233,60091,46590,25086,84844,33636,06628,26525,12019,95626,30432,54331,26830,96429,51141,11048,67048,12523,73622,05522,43217,39517,0231,6851,8521,8912,1752,0132,0054,98910,65511,17611,76320,8001,1601,3501,3871,2461,6131,8231,5871,4833,3483,8293,9614,1004,2594,6954,6614,0683,051000000100000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,953
2,781
0
0
0
0
0
0
0
0
1,419
1,805
1,632
5,815
61,628
5,806
6,083
5,987
6,590
6,817
8,410
4,695
8,433
13,887
17,092
24,966
17,259
0
0
0
67,500
0
0
0
63,900
36,300
40,600
40,800
53,200
3,100
2,600
40,000
94,900
1,100
93,400
113,800
71,800
59,700
57,900
0
0
0057,90059,70071,800113,80093,4001,10094,90040,0002,6003,10053,20040,80040,60036,30063,90000067,50000017,25924,96617,09213,8878,4334,6958,4106,8176,5905,9876,0835,80661,6285,8151,6321,8051,419000000002,7812,95300000000000000000000000000000
> Total Stockholder Equity
0
0
0
22,949
0
0
0
59,737
0
0
56,759
138,472
138,021
140,020
143,493
171,159
178,597
181,115
192,829
199,349
212,095
228,852
235,382
241,199
247,088
260,221
276,292
369,464
354,052
377,248
381,292
414,246
409,594
419,688
427,044
441,358
435,588
449,530
467,306
489,618
477,495
487,767
513,138
553,201
537,878
562,251
605,312
660,017
666,982
672,672
547,623
596,205
610,419
620,599
663,710
912,345
881,280
938,346
966,649
1,010,900
987,700
988,900
1,035,000
1,088,500
1,074,800
1,198,800
1,251,500
1,447,000
1,522,800
1,543,700
1,522,700
1,619,000
1,575,300
1,513,200
1,449,300
1,383,000
1,202,600
956,300
697,200
649,300
649,300697,200956,3001,202,6001,383,0001,449,3001,513,2001,575,3001,619,0001,522,7001,543,7001,522,8001,447,0001,251,5001,198,8001,074,8001,088,5001,035,000988,900987,7001,010,900966,649938,346881,280912,345663,710620,599610,419596,205547,623672,672666,982660,017605,312562,251537,878553,201513,138487,767477,495489,618467,306449,530435,588441,358427,044419,688409,594414,246381,292377,248354,052369,464276,292260,221247,088241,199235,382228,852212,095199,349192,829181,115178,597171,159143,493140,020138,021138,47256,7590059,73700022,949000
   Common Stock
0
0
0
19
0
0
0
22
0
0
23
28
28
30
30
30
30
30
30
30
30
30
31
31
31
31
31
35
35
36
36
36
36
36
36
36
36
36
37
37
38
38
38
38
38
39
39
40
40
41
41
41
41
41
41
50
50
51
51
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
10010010010010010010010010010010010010010010010010010010010010051515050414141414141404039393838383838373736363636363636363635353131313131303030303030303030282823002200019000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
166,663
168,212
0
0
0
0
0
212,330
222,814
236,305
251,528
231,292
236,321
258,152
0
266,749
280,850
317,792
351,139
355,130
344,184
214,686
254,480
264,965
269,581
303,132
337,074
299,639
349,783
370,728
367,300
341,300
331,700
374,900
421,800
409,300
502,000
541,500
726,900
796,600
801,200
768,500
957,800
954,100
897,700
822,000
734,000
551,000
289,700
0
0
00289,700551,000734,000822,000897,700954,100957,800768,500801,200796,600726,900541,500502,000409,300421,800374,900331,700341,300367,300370,728349,783299,639337,074303,132269,581264,965254,480214,686344,184355,130351,139317,792280,850266,7490258,152236,321231,292251,528236,305222,814212,33000000168,212166,66300000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-5,657
0
0
0
-276
0
0
-182
-473
-643
-954
-1,117
-1,130
-946
-1,215
-1,040
-859
-939
-1,214
-1,130
-1,476
-1,261
-1,641
-2,173
-2,110
-2,803
-2,771
-2,894
-3,313
-3,229
-3,249
-3,901
-4,129
-3,759
-3,513
-3,502
-3,465
-3,391
-3,251
-3,810
-3,008
-3,242
-3,657
-4,152
-2,713
-4,152
-3,080
-3,572
-4,331
-3,747
-3,519
-3,815
-3,698
-3,251
-4,415
-4,666
-5,500
-4,500
-5,000
-9,100
-9,900
-21,200
-22,200
-21,400
-25,300
-24,400
-22,400
-23,100
-16,100
-9,300
-6,100
-5,200
3,100
1,000
-1,600
-2,600
-5,700
-5,700-2,600-1,6001,0003,100-5,200-6,100-9,300-16,100-23,100-22,400-24,400-25,300-21,400-22,200-21,200-9,900-9,100-5,000-4,500-5,500-4,666-4,415-3,251-3,698-3,815-3,519-3,747-4,331-3,572-3,080-4,152-2,713-4,152-3,657-3,242-3,008-3,810-3,251-3,391-3,465-3,502-3,513-3,759-4,129-3,901-3,249-3,229-3,313-2,894-2,771-2,803-2,110-2,173-1,641-1,261-1,476-1,130-1,214-939-859-1,040-1,215-946-1,130-1,117-954-643-473-18200-276000-5,657000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
213,320
215,938
0
0
0
0
0
232,887
236,099
240,372
247,637
255,675
260,778
264,877
0
280,653
291,339
297,953
317,971
322,384
337,947
342,888
352,435
355,661
360,999
370,855
618,416
624,484
632,569
640,178
688,600
690,200
701,800
708,800
716,100
726,200
758,500
770,900
784,900
790,100
804,400
816,800
829,400
834,800
849,200
860,100
873,500
878,200
895,800
0
0
00895,800878,200873,500860,100849,200834,800829,400816,800804,400790,100784,900770,900758,500726,200716,100708,800701,800690,200688,600640,178632,569624,484618,416370,855360,999355,661352,435342,888337,947322,384317,971297,953291,339280,6530264,877260,778255,675247,637240,372236,099232,88700000215,938213,32000000000000000000000000000000
   Treasury Stock00-227,700-227,700-227,700-227,700-227,700-204,400-152,200-39,600-39,600-39,600-39,600-39,600-39,600-39,600-39,600-39,700-39,700-39,600-39,600-39,642-39,642-39,642-39,497-6,503-6,503-6,501-6,420-6,420-6,420-6,420-6,420-6,320-6,320-6,320-6,320-6,119-6,119-6,119-6,119-5,906-5,906-5,906-5,906-1,4570000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
13,267
0
0
0
34,595
0
0
35,079
90,920
93,936
101,203
101,992
101,933
102,163
103,134
104,288
109,170
110,877
113,066
118,563
120,492
123,643
127,349
130,832
197,689
204,367
213,320
215,938
220,654
222,746
225,231
226,623
225,058
226,981
230,193
234,466
241,518
249,556
254,659
258,758
267,902
274,333
285,019
291,633
311,551
315,964
331,527
336,468
346,015
349,160
354,496
364,352
578,919
584,842
592,927
600,536
649,000
650,600
662,100
669,100
676,500
686,600
718,900
731,300
745,300
750,500
764,800
777,200
661,100
630,400
621,500
632,400
645,800
650,500
668,100
672,000
676,700
676,700672,000668,100650,500645,800632,400621,500630,400661,100777,200764,800750,500745,300731,300718,900686,600676,500669,100662,100650,600649,000600,536592,927584,842578,919364,352354,496349,160346,015336,468331,527315,964311,551291,633285,019274,333267,902258,758254,659249,556241,518234,466230,193226,981225,058226,623225,231222,746220,654215,938213,320204,367197,689130,832127,349123,643120,492118,563113,066110,877109,170104,288103,134102,163101,933101,992101,20393,93690,92035,0790034,59500013,267000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,120,900
Cost of Revenue-693,700
Gross Profit427,200427,200
 
Operating Income (+$)
Gross Profit427,200
Operating Expense-593,200
Operating Income-166,000-166,000
 
Operating Expense (+$)
Research Development193,000
Selling General Administrative372,900
Selling And Marketing Expenses0
Operating Expense593,200565,900
 
Net Interest Income (+$)
Interest Income0
Interest Expense-37,300
Other Finance Cost-41,700
Net Interest Income-79,000
 
Pretax Income (+$)
Operating Income-166,000
Net Interest Income-79,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-221,700-110,300
EBIT - interestExpense = -203,300
-221,700
-186,500
Interest Expense37,300
Earnings Before Interest and Taxes (EBIT)-166,000-184,400
Earnings Before Interest and Taxes (EBITDA)-34,400
 
After tax Income (+$)
Income Before Tax-221,700
Tax Provision-49,400
Net Income From Continuing Ops-790,200-271,100
Net Income-223,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,286,900
Total Other Income/Expenses Net-55,70079,000
 

Technical Analysis of Emergent Biosolutions Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Emergent Biosolutions Inc. The general trend of Emergent Biosolutions Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Emergent Biosolutions Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Emergent Biosolutions Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.105 < 2.12 < 2.718.

The bearish price targets are: 1.84 > 1.48 > 1.42.

Tweet this
Emergent Biosolutions Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Emergent Biosolutions Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Emergent Biosolutions Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Emergent Biosolutions Inc. The current macd is -0.14394097.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Emergent Biosolutions Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Emergent Biosolutions Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Emergent Biosolutions Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Emergent Biosolutions Inc Daily Moving Average Convergence/Divergence (MACD) ChartEmergent Biosolutions Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Emergent Biosolutions Inc. The current adx is 14.31.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Emergent Biosolutions Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Emergent Biosolutions Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Emergent Biosolutions Inc. The current sar is 2.24914953.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Emergent Biosolutions Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Emergent Biosolutions Inc. The current rsi is 32.75. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Emergent Biosolutions Inc Daily Relative Strength Index (RSI) ChartEmergent Biosolutions Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Emergent Biosolutions Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Emergent Biosolutions Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Emergent Biosolutions Inc Daily Stochastic Oscillator ChartEmergent Biosolutions Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Emergent Biosolutions Inc. The current cci is -151.19254022.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Emergent Biosolutions Inc Daily Commodity Channel Index (CCI) ChartEmergent Biosolutions Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Emergent Biosolutions Inc. The current cmo is -53.9440974.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Emergent Biosolutions Inc Daily Chande Momentum Oscillator (CMO) ChartEmergent Biosolutions Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Emergent Biosolutions Inc. The current willr is -94.92043285.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Emergent Biosolutions Inc Daily Williams %R ChartEmergent Biosolutions Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Emergent Biosolutions Inc.

Emergent Biosolutions Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Emergent Biosolutions Inc. The current atr is 0.1981281.

Emergent Biosolutions Inc Daily Average True Range (ATR) ChartEmergent Biosolutions Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Emergent Biosolutions Inc. The current obv is 31,882,561.

Emergent Biosolutions Inc Daily On-Balance Volume (OBV) ChartEmergent Biosolutions Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Emergent Biosolutions Inc. The current mfi is 37.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Emergent Biosolutions Inc Daily Money Flow Index (MFI) ChartEmergent Biosolutions Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Emergent Biosolutions Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Emergent Biosolutions Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Emergent Biosolutions Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.749
Ma 20Greater thanMa 502.253
Ma 50Greater thanMa 1002.376
Ma 100Greater thanMa 2002.257
OpenGreater thanClose1.900
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Emergent Biosolutions Inc with someone you think should read this too:
  • Are you bullish or bearish on Emergent Biosolutions Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Emergent Biosolutions Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Emergent Biosolutions Inc

I send you an email if I find something interesting about Emergent Biosolutions Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Emergent Biosolutions Inc.

Receive notifications about Emergent Biosolutions Inc in your mailbox!